PCN39 COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF USING TEMSIROLIMUS COMPARED TO INTERFERON ALPHA IN METASTATIC RENAL CELL CARCINOMA
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74290-X
https://www.valueinhealthjournal.com/article/S1098-3015(10)74290-X/fulltext
Title :
PCN39 COST-EFFECTIVENESS AND BUDGET IMPACT ANALYSIS OF USING TEMSIROLIMUS COMPARED TO INTERFERON ALPHA IN METASTATIC RENAL CELL CARCINOMA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74290-X&doi=10.1016/S1098-3015(10)74290-X
First page :
Section Title :
Open access? :
No
Section Order :
214